These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines. Zhang Y; Banga Ndzouboukou JL; Gan M; Lin X; Fan X Front Immunol; 2021; 12():771242. PubMed ID: 34880867 [TBL] [Abstract][Full Text] [Related]
6. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients. Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082 [TBL] [Abstract][Full Text] [Related]
7. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2. Sharma D Expert Rev Vaccines; 2021 Sep; 20(9):1051-1057. PubMed ID: 34313516 [TBL] [Abstract][Full Text] [Related]
8. Immune response scenario and vaccine development for SARS-CoV-2 infection. Mohammad MHS Int Immunopharmacol; 2021 May; 94():107439. PubMed ID: 33571745 [TBL] [Abstract][Full Text] [Related]
9. Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses. Jordan SC Clin Exp Immunol; 2021 Jun; 204(3):310-320. PubMed ID: 33534923 [TBL] [Abstract][Full Text] [Related]
10. The Immune Responses against Coronavirus Infections: Friend or Foe? Vafaeinezhad A; Atashzar MR; Baharlou R Int Arch Allergy Immunol; 2021; 182(9):863-876. PubMed ID: 33951640 [TBL] [Abstract][Full Text] [Related]
11. Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses. Tomalka JA; Suthar MS; Deeks SG; Sekaly RP Nat Immunol; 2022 Mar; 23(3):360-370. PubMed ID: 35210622 [TBL] [Abstract][Full Text] [Related]
12. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism. Policard M; Jain S; Rego S; Dakshanamurthy S Virus Res; 2021 Aug; 301():198464. PubMed ID: 34058265 [TBL] [Abstract][Full Text] [Related]
13. Severe Acute Respiratory Syndrome Coronavirus 2: The Role of the Main Components of the Innate Immune System. Anaeigoudari A; Mollaei HR; Arababadi MK; Nosratabadi R Inflammation; 2021 Dec; 44(6):2151-2169. PubMed ID: 34524614 [TBL] [Abstract][Full Text] [Related]
14. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting. Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J Front Immunol; 2021; 12():802858. PubMed ID: 35003131 [TBL] [Abstract][Full Text] [Related]
15. Quantitative Insight into Immunopathology of SARS-CoV-2 Infection. Soni B; Kabra R; Singh S J Interferon Cytokine Res; 2021 Jul; 41(7):244-257. PubMed ID: 34280026 [TBL] [Abstract][Full Text] [Related]
16. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D. Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735 [TBL] [Abstract][Full Text] [Related]
17. An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants. Kayesh MEH; Kohara M; Tsukiyama-Kohara K Viruses; 2021 Nov; 13(11):. PubMed ID: 34835108 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Immune Response between SARS, MERS, and COVID-19 Infection, Perspective on Vaccine Design and Development. Ansariniya H; Seifati SM; Zaker E; Zare F Biomed Res Int; 2021; 2021():8870425. PubMed ID: 33564683 [TBL] [Abstract][Full Text] [Related]
19. Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges. Abdullahi IN; Emeribe AU; Adekola HA; Abubakar SD; Dangana A; Shuwa HA; Nwoba ST; Mustapha JO; Haruna MT; Olowookere KA; Animasaun OS; Ugwu CE; Onoja SO; Gadama AS; Mohammed M; Daneji IM; Amadu DO; Ghamba PE; Onukegbe NB; Shehu MS; Isomah C; Babayo A; Ahmad AE Hum Vaccin Immunother; 2021 Mar; 17(3):620-637. PubMed ID: 32936732 [TBL] [Abstract][Full Text] [Related]
20. Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants. Noor R Viruses; 2022 Nov; 14(11):. PubMed ID: 36423150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]